Tumor Hypoxia Directed Multimodal Nanotherapy for Overcoming Drug Resistance in Renal Cell Carcinoma and Reprogramming Macrophages

Drug resistance is one of the significant clinical burden in renal cell carcinoma (RCC). The development of drug resistance is attributed to many factors, including impairment of apoptosis, elevation of carbonic anhydrase IX (CA IX, a marker of tumor hypoxia), and infiltration of tumorigenic immune...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomaterials
Main Authors: Alsaab, Hashem O., Sau, Samaresh, Alzhrani, Rami M., Cheriyan, Vino T., Polin, Lisa A., Vaishampayan, Ulka, Rishi, Arun K., Iyer, Arun K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6414719/
https://ncbi.nlm.nih.gov/pubmed/30179778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2018.08.053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados